HIKAL
|
The Current P/B Ratio of HIKAL is 4.45.
Share Price | ₹428.3 | Dec 11,2024 |
Market Cap | ₹5,280.3 Cr | |
Book Value | ₹1,187.7 Cr | Mar2024 - Consolidated Results |
Price/Book | 4.45x | Calculated as MarketCap/Book Value |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PB (Price/Book ) ratio of HIKAL
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹5,280.3 Cr] as on Dec 11,2024
(/) Book Value [ ₹1,187.7 Cr] based on Mar2024 - Consolidated Results
(=) P/B Ratio [ 4.45x ]
Thus, for HIKAL , the investors are currently willing to pay '4.45 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of HIKAL !
The chart below summarizes the trend in P/B Ratio of HIKAL over the last five years.
Historical PB (Price/Book ) ratio chart of HIKAL
PB Ratio Performance Analysis for HIKAL
- HIKAL 's p/b ratio for fiscal years ending Mar2024 to Mar2020 averaged 2.69x.
- HIKAL 's operated at median p/b ratio of 2.75x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, HIKAL 's p/b ratio peaked in Mar2022 at 4.65x.
- HIKAL 's p/b ratio hit its five-year low in Mar2020 of 1.06x.
How does HIKAL 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
---|---|---|---|
HIKAL | 1,187.66 | 4.45 | 5,280.3 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 63,666.80 | 6.84 | 435,407.0 |
CIPLA LTD | 26,619.90 | 4.41 | 117,443.0 |
DR REDDYS LABORATORIES LTD | 28,123.50 | 3.67 | 103,338.0 |
ZYDUS LIFESCIENCES LTD | 19,829.50 | 5.00 | 99,244.9 |
DIVIS LABORATORIES LTD | 13,571.00 | 11.60 | 157,489.0 |
MANKIND PHARMA LTD | 9,339.84 | 11.25 | 105,098.0 |
TORRENT PHARMACEUTICALS LTD | 6,856.15 | 16.66 | 114,202.0 |
LUPIN LTD | 14,175.80 | 6.92 | 98,055.1 |
AUROBINDO PHARMA LTD | 29,842.80 | 2.39 | 71,188.9 |
ABBOTT INDIA LTD | 3,658.73 | 16.76 | 61,336.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs HIKAL 's P/B Ratio
Top 10 Industry Peers | PB Ratio |
---|---|
Min industry PB | 2.39x |
Max industry PB | 16.76x |
Median industry PB | 6.84x |
Average industry PB | 8.18x |
You may also like the below Video Courses